Repositioning Candidate Details

Candidate ID: R0397
Source ID: DB01089
Source Type: approved
Compound Type: small molecule
Compound Name: Deserpidine
Synonyms: (3β,16β,17α,18β,20α)-17-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester; 11-demethoxyreserpine; 11-desmethoxyreserpine; Canescine; Deserpidine; Raunormine; Recanescine
Molecular Formula: C32H38N2O8
SMILES: [H][C@]12C[C@@H](OC(=O)C3=CC(OC)=C(OC)C(OC)=C3)[C@H](OC)[C@@H](C(=O)OC)[C@@]1([H])C[C@@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2
Structure:
DrugBank Description: Deserpidine is an ester alkaloid drug isolated from Rauwolfia canescens (family Apocynaceae) with antipsychotic and antihypertensive properties that has been used for the control of high blood pressure and for the relief of psychotic behavior.
CAS Number: 131-01-1
Molecular Weight: 578.6527
DrugBank Indication: For the treatment of hypertension.
DrugBank Pharmacology: Deserpidine, an alkaloid of <i>Rauwolfia canescens</i>, is used as an antihypertensive. Rauwolfia alkaloids work by controlling nerve impulses along certain nerve pathways. As a result, they act on the heart and blood vessels to lower blood pressure.
DrugBank MoA: Deserpidine's mechanism of action is through inhibition of the ATP/Mg<sup>2+</sup> pump responsible for the sequestering of neurotransmitters into storage vesicles located in the presynaptic neuron. The neurotransmitters that are not sequestered in the storage vesicle are readily metabolized by monoamine oxidase (MAO) causing a reduction in catecholamines.
Targets: Synaptic vesicular amine transporter inhibitor
Inclusion Criteria: Therapeutic strategy associated